← Leaderboards
Richard A Houghten
Mixture Sciences, Inc.
$8,655,813
Attributed
$8,994,629
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–20$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$13,680,877 · 13
By mechanism
P01$5,111,349 · 2
R01$3,275,534 · 3
P41$2,923,133 · 2
R21$1,421,928 · 3
U19$496,734 · 1
N01$452,199 · 2
Top collaborators
- Stella Marie Bernardo2 shared
- Samuel Austin Lee2 shared
- Larry A. Sklar2 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseLibrariesSmall MoleculeLeadSmall Molecule LibrariesPropertyScreening ProcedureIn VivoLaboratoriesPharmaceutical PreparationsMethodologyIn VitroSolubilityPiperazinesDesignCombinatorialHeterocyclic CompoundsMolecular BankPeptide LibraryMolecularPreparationIn Vivo ModelInstitutesPositioning Attribute
Grant awards (32)
A High-Throughput Chemical Screen to Identify Inhibitors of the Fungal Azole Transporter Cdr1p$178,678
R21 · FY2020 · AI
A High-Throughput Chemical Screen to Identify Inhibitors of the Fungal Azole Transporter Cdr1p$273,077
R21 · FY2019 · AI
Novel cyclic lipopeptides for treating gram negative bacterial infections$252,175
R21 · FY2016 · AI · contact PI
High throughput in vivo screening: translational generation of novel analgesics$369,833
R01 · FY2015 · DA · contact PI
Novel cyclic lipopeptides for treating gram negative bacterial infections$222,958
R21 · FY2015 · AI · contact PI
High throughput in vivo screening: translational generation of novel analgesics$437,704
R01 · FY2014 · DA · contact PI
High throughput in vivo screening: translational generation of novel analgesics$511,211
R01 · FY2013 · DA · contact PI
High throughput in vivo screening: translational generation of novel analgesics$501,681
R01 · FY2012 · DA · contact PI
High throughput in vivo screening: translational generation of novel analgesics$407,964
R01 · FY2011 · DA · contact PI
Highly Diverse and Structurally Varied Heterocyclic Libraries for the MLSMR$459,036
P41 · FY2009 · GM · contact PI
Chemical Libraries and Screening$294,022
U19 · FY2009 · CA · contact PI
Stereochemically and Structurally Diverse Pilot Scale Libraries for the MLSMR$175,023
P41 · FY2009 · GM · contact PI
Highly Diverse and Structurally Varied Heterocyclic Libraries for the MLSMR$459,036
P41 · FY2008 · GM · contact PI
Stereochemically and Structurally Diverse Pilot Scale Libraries for the MLSMR$430,711
P41 · FY2008 · GM · contact PI
In Vivo Screening of Mixture-Based Combinatorial Libraries$267,540
R21 · FY2008 · DA · contact PI
Chemical Libraries and Screening$202,712
U19 · FY2008 · CA · contact PI
Highly Diverse and Structurally Varied Heterocyclic Libraries for the MLSMR$487,608
P41 · FY2007 · GM · contact PI
Stereochemically and Structurally Diverse Pilot Scale Libraries for the MLSMR$439,053
P41 · FY2007 · GM · contact PI
In Vivo Screening of Mixture-Based Combinatorial Libraries$227,500
R21 · FY2007 · DA · contact PI
Stereochemically /Structurally Diverse Pilot Scale Libra$472,666
P41 · FY2006 · GM · contact PI
COMBINATORIAL APPROACHES TO TREAT NEOPLASTIC DISEASES$1,506,546
P01 · FY2002 · CA
IDENTIFICATION OF RECEPTOR SPECIFIC OPIOID LIGANDS$284,980
R01 · FY2002 · DA
DEVELOPMENT OF HETEROCYCLIC &SMALL MOLECULE ORGANIC COMBINATORIAL LIBRARIES$197,079
P01 · FY2002 · CA
COMBINATORIAL APPROACHES TO TREAT NEOPLASTIC DISEASES$1,753,167
P01 · FY2001 · CA
IDENTIFICATION OF RECEPTOR SPECIFIC OPIOID LIGANDS$284,980
R01 · FY2001 · DA
DEVELOPMENT OF HETEROCYCLIC &SMALL MOLECULE ORGANIC COMBINATORIAL LIBRARIES$0
P01 · FY2001 · CA
COMBINATORIAL APPROACHES TO TREAT NEOPLASTIC DISEASES$1,426,535
P01 · FY2000 · CA
SYNTHESIS AND DISTRIBUTION OF OPIOID &RELATED PEPTIDES$452,199
N01 · FY2000 · DA
IDENTIFICATION OF RECEPTOR SPECIFIC OPIOID LIGANDS$284,980
R01 · FY2000 · DA
DEVELOPMENT OF HETEROCYCLIC &SMALL MOLECULE ORGANIC COMBINATORIAL LIBRARIES$228,022
P01 · FY2000 · CA
SMALL MOLECULE ORPHANIN FQ/NOCICEPTIN RECEPTOR LIGANDS$192,201
R01 · FY2000 · DA
MAINTENANCE &OPERATION OF A SYNTHETIC PEPTIDE FACILITY$0
N01 · FY2000 · HD